Clinical Trials
35
Active:2
Completed:27
Trial Phases
5 Phases
Phase 1:2
Phase 2:3
Phase 3:6
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (27 trials with phase data)• Click on a phase to view related trials
Phase 4
13 (48.1%)Phase 3
6 (22.2%)Not Applicable
3 (11.1%)Phase 2
3 (11.1%)Phase 1
2 (7.4%)Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy
Phase 2
Active, not recruiting
- Conditions
- Chronic Hand Eczema
- Interventions
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2025-10-20
- Lead Sponsor
- Innovaderm Research Inc.
- Target Recruit Count
- 84
- Registration Number
- NCT06283550
- Locations
- 🇵🇱
INNO-6052 Site 19, Krakow, Poland
🇵🇱INNO-6052 Site 17, Lodz, Poland
🇵🇱INNO-6052 Site 21, Lublin, Poland
Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects With Discoid Lupus Erythematosus
Phase 2
Recruiting
- Conditions
- Discoid Lupus Erythematosus
- Interventions
- Procedure: Application without occlusion in Area 1Procedure: Application under occlusion at night in Area 1Procedure: Application under occlusion at night in Area 2Procedure: Application without occlusion in Area 2
- First Posted Date
- 2024-02-15
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- Innovaderm Research Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT06261021
- Locations
- 🇨🇦
INNO-6051 Site 03, Fredericton, New Brunswick, Canada
🇨🇦Innovaderm Research Inc., Montréal, Quebec, Canada
Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
Recruiting
- Conditions
- Chronic Hand EczemaPlaque PsoriasisPalmoplantar PustulosisAtopic DermatitisAcneHidradenitis Suppurativa
- First Posted Date
- 2023-08-16
- Last Posted Date
- 2025-01-31
- Lead Sponsor
- Innovaderm Research Inc.
- Target Recruit Count
- 500
- Registration Number
- NCT05994976
- Locations
- 🇨🇦
Innovaderm Research Inc., Montréal, Quebec, Canada
Short-Term Efficacy of Triamcinolone Acetonide (Aristocort® C) in Subjects With Atopic Dermatitis
Phase 4
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: Vehicle
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Innovaderm Research Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT05844618
- Locations
- 🇨🇦
Innovaderm Research Inc., Montréal, Quebec, Canada
Study to Assess the Reliability of PASI Scoring Using Digital-Based Images
Completed
- Conditions
- Plaque Psoriasis
- First Posted Date
- 2023-04-28
- Last Posted Date
- 2025-09-12
- Lead Sponsor
- Innovaderm Research Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT05835843
- Locations
- 🇨🇦
Innovaderm Research, Montreal, Quebec, Canada
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
News
No news found